![Dámaso Molero](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dámaso Molero
Directeur Général chez 3P Biopharmaceuticals SL
Postes actifs de Dámaso Molero
Sociétés | Poste | Début | Fin |
---|---|---|---|
3P Biopharmaceuticals SL
![]() 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Directeur Général | 01/04/2007 | - |
President | 16/12/2009 | 30/01/2014 |
Historique de carrière de Dámaso Molero
Anciens postes connus de Dámaso Molero
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHIONOGI & CO., LTD. | Corporate Officer/Principal | - | - |
ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
Syntex, Inc. | Corporate Officer/Principal | - | - |
Glaxo, Inc. | Corporate Officer/Principal | - | - |
Formation de Dámaso Molero
University of Navarra | Masters Business Admin |
Statistiques
Internationale
Espagne | 3 |
Canada | 3 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Chief Executive Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
SHIONOGI & CO., LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
3P Biopharmaceuticals SL
![]() 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
Glaxo, Inc. | |
Syntex, Inc. | Miscellaneous |
- Bourse
- Insiders
- Dámaso Molero
- Expérience